Moreover, acute clinical deterioration in moderate COVID-19 patients requiring inpatient care may be the result of increased inflammation due to elevated cytokine levels, such as type I IFNs and IL-6 [7,8], all of which transmit their signals through the JAK-STAT pathway. This evidence concerns the gene IL6 and COVID-19.